Post-stroke dysphagia (a difficulty in swallowing after a stroke) is a common and expensive
complication of acute stroke and is associated with increased mortality, morbidity, and …

We have provided an overview on the profound impact of COVID‐19 upon older people with
Alzheimer's disease and other dementias and the challenges encountered in our …

Small vessel disease encompasses lacunar stroke, white matter hyperintensities, lacunes
and microbleeds. It causes a quarter of all ischemic strokes, is the commonest cause of …

Increasing evidence recognizes Alzheimer's disease (AD) as a multifactorial and
heterogeneous disease with multiple contributors to its pathophysiology, including vascular …

Background Comparisons between ticagrelor and clopidogrel for the secondary prevention
of stroke in CYP2C19 loss-of-function carriers have not been extensively performed …

Background Thrombolytic therapy for acute ischemic stroke with a lower-than-standard dose
of intravenous alteplase may improve recovery along with a reduced risk of intracerebral …

Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg
meetings, were convened to review the scientific evidence and the state of current services …

Background Tranexamic acid can prevent death due to bleeding after trauma and post-
partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma …

Background CTX0E03 is an immortalised human neural stem-cell line from which a drug
product (CTX-DP) was developed for allogeneic therapy. Dose-dependent improvement in …

Background Systolic blood pressure of more than 185 mm Hg is a contraindication to
thrombolytic treatment with intravenous alteplase in patients with acute ischaemic stroke, but …